Remaining life expectancy measurement and PSA screening of older men-Reference-Cited by-同舟云学术

Remaining life expectancy measurement and PSA screening of older men

Published:2012-07 Issue:3 Volume:3 Page:196-204
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Kotwal Ashwin A.,Mohile Supriya G.,Dale William

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference51 articles.

1. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?;Sirovich;JAMA,2003

2. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey;Ross;Prev Med,2004

3. Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey;Finney Rutten;Prev Med,2005

4. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System;Li;Prev Chronic Dis,2010

5. The role of anxiety in prostate carcinoma;Dale;Cancer,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Screening in Older Adults;Medical Clinics of North America;2020-11

2. Factors associated with appropriate and low-value PSA testing;Cancer Epidemiology;2020-06

3. Are We Choosing Wisely? Older Adults’ Cancer Screening Intentions and Recalled Discussions with Physicians About Stopping;Journal of General Internal Medicine;2019-05-30

4. Mathematical determination of some oncological parameters and their therapeutic implications in dogs;Comparative Clinical Pathology;2018-12-12

5. Predicting 7-year mortality for use with evidence-based guidelines for Prostate-Specific Antigen (PSA) testing: findings from a large prospective study of 123 697 Australian men;BMJ Open;2018-12